Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2014

Open Access 01-12-2014 | Original investigation

High glucose induces human endothelial dysfunction through an Axl-dependent mechanism

Authors: Chien-Hsing Lee, Yi-Shing Shieh, Fone-Ching Hsiao, Feng-Chih Kuo, Chih-Yuan Lin, Chang-Hsun Hsieh, Yi-Jen Hung

Published in: Cardiovascular Diabetology | Issue 1/2014

Login to get access

Abstract

Background

The receptor tyrosine kinase Axl and its ligand growth arrest-specific protein 6 (Gas6) are involved in the diabetic vascular disease. The aim of this study was to explore the role of Gas6/Axl system in high glucose (HG)-induced endothelial dysfunction.

Methods

We investigated the effect of various glucose concentrations on Axl signaling in human microvascular endothelial cells (HMEC-1 s).

Results

Human plasma Gas6 value inversely correlated with glucose status, endothelial markers. HG decreased Gas6/Axl expression and increased intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression in HMEC-1 s. HG significantly decreased HMEC-1 s cell viability and tube formation and promoted monocyte-EC adhesion. Down-regulation of Akt phosphorylation was found in HG culture. Axl transfection significantly reversed HG-induced Akt phosphorylation, VCAM-1 expression and endothelial dysfunction. We also found additive changes in Axl-shRNA-infected HMEC-1 cells in HG culture. Furthermore, Axl overexpression in HMEC-1 s significantly reversed HG-induced vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2) expression. In addition, significantly lower Axl and VEGFR2 expression in arteries were found in diabetic patients as compared with non-diabetic patients.

Conclusions

This study demonstrates that HG can alter Gas6/Axl signaling and may through Akt and VEGF/VEGFR2 downstream molecules and suggests that Gas6/Axl may involve in HG-induced EC dysfunction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
2.
go back to reference Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321 (7258): 405-412. 10.1136/bmj.321.7258.405.PubMedCentralCrossRefPubMed Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321 (7258): 405-412. 10.1136/bmj.321.7258.405.PubMedCentralCrossRefPubMed
3.
go back to reference Ishibashi Y, Matsui T, Maeda S, Higashimoto Y, Yamagishi S: Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. Cardiovasc Diabetol. 2013, 12: 125-10.1186/1475-2840-12-125.PubMedCentralCrossRefPubMed Ishibashi Y, Matsui T, Maeda S, Higashimoto Y, Yamagishi S: Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. Cardiovasc Diabetol. 2013, 12: 125-10.1186/1475-2840-12-125.PubMedCentralCrossRefPubMed
4.
go back to reference Xu Y, He Z, King GL: Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications. Curr Diab Rep. 2005, 5 (2): 91-97. 10.1007/s11892-005-0034-z.CrossRefPubMed Xu Y, He Z, King GL: Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications. Curr Diab Rep. 2005, 5 (2): 91-97. 10.1007/s11892-005-0034-z.CrossRefPubMed
5.
go back to reference Hartge MM, Kintscher U, Unger T: Endothelial dysfunction and its role in diabetic vascular disease. Endocrinol Metab Clin North Am. 2006, 35 (3): 551-560. 10.1016/j.ecl.2006.06.006. viii-ixCrossRefPubMed Hartge MM, Kintscher U, Unger T: Endothelial dysfunction and its role in diabetic vascular disease. Endocrinol Metab Clin North Am. 2006, 35 (3): 551-560. 10.1016/j.ecl.2006.06.006. viii-ixCrossRefPubMed
6.
go back to reference Moriya J, Ferrara N: Inhibiting the response to VEGF in diabetes. Sci Signal. 2014, 7 (307): e1.CrossRef Moriya J, Ferrara N: Inhibiting the response to VEGF in diabetes. Sci Signal. 2014, 7 (307): e1.CrossRef
7.
go back to reference Hafizi S, Dahlback B: Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J. 2006, 273 (23): 5231-5244. 10.1111/j.1742-4658.2006.05529.x.CrossRefPubMed Hafizi S, Dahlback B: Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J. 2006, 273 (23): 5231-5244. 10.1111/j.1742-4658.2006.05529.x.CrossRefPubMed
8.
go back to reference Linger RM, Keating AK, Earp HS, Graham DK: TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res. 2008, 100: 35-83.PubMedCentralCrossRefPubMed Linger RM, Keating AK, Earp HS, Graham DK: TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res. 2008, 100: 35-83.PubMedCentralCrossRefPubMed
9.
go back to reference Laurance S, Lemarie CA, Blostein MD: Growth arrest-specific gene 6 (gas6) and vascular hemostasis. Adv Nutr. 2012, 3 (2): 196-203. 10.3945/an.111.001826.PubMedCentralCrossRefPubMed Laurance S, Lemarie CA, Blostein MD: Growth arrest-specific gene 6 (gas6) and vascular hemostasis. Adv Nutr. 2012, 3 (2): 196-203. 10.3945/an.111.001826.PubMedCentralCrossRefPubMed
10.
go back to reference Robins RS, Lemarie CA, Laurance S, Aghourian MN, Wu J, Blostein MD: Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice. Blood. 2013, 121 (4): 692-699. 10.1182/blood-2012-05-433730.CrossRefPubMed Robins RS, Lemarie CA, Laurance S, Aghourian MN, Wu J, Blostein MD: Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice. Blood. 2013, 121 (4): 692-699. 10.1182/blood-2012-05-433730.CrossRefPubMed
11.
go back to reference Tjwa M, Bellido-Martin L, Lin Y, Lutgens E, Plaisance S, Bono F, Delesque-Touchard N, Herve C, Moura R, Billiau AD, Aparicio C, Levi M, Daemen M, Dewerchin M, Lupu F, Arnout J, Herbert JM, Waer M, Garcia de Frutos P, Dahlback B, Carmeliet P, Hoylaerts MF, Moons L: Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood. 2008, 111 (8): 4096-4105. 10.1182/blood-2007-05-089565.CrossRefPubMed Tjwa M, Bellido-Martin L, Lin Y, Lutgens E, Plaisance S, Bono F, Delesque-Touchard N, Herve C, Moura R, Billiau AD, Aparicio C, Levi M, Daemen M, Dewerchin M, Lupu F, Arnout J, Herbert JM, Waer M, Garcia de Frutos P, Dahlback B, Carmeliet P, Hoylaerts MF, Moons L: Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood. 2008, 111 (8): 4096-4105. 10.1182/blood-2007-05-089565.CrossRefPubMed
12.
go back to reference Lutgens E, Tjwa M, Garcia De Frutos P, Wijnands E, Beckers L, Dahlback B, Daemen MJ, Carmeliet P, Moons L: Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J Pathol. 2008, 216 (1): 55-63. 10.1002/path.2381.CrossRefPubMed Lutgens E, Tjwa M, Garcia De Frutos P, Wijnands E, Beckers L, Dahlback B, Daemen MJ, Carmeliet P, Moons L: Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J Pathol. 2008, 216 (1): 55-63. 10.1002/path.2381.CrossRefPubMed
13.
go back to reference Ekman C, Gottsater A, Lindblad B, Dahlback B: Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin Biochem. 2010, 43 (10–11): 873-876.CrossRefPubMed Ekman C, Gottsater A, Lindblad B, Dahlback B: Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin Biochem. 2010, 43 (10–11): 873-876.CrossRefPubMed
14.
go back to reference Clauser S, Meilhac O, Bieche I, Raynal P, Bruneval P, Michel JB, Borgel D: Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques. Thromb Haemost. 2012, 107 (1): 140-149.CrossRefPubMed Clauser S, Meilhac O, Bieche I, Raynal P, Bruneval P, Michel JB, Borgel D: Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques. Thromb Haemost. 2012, 107 (1): 140-149.CrossRefPubMed
15.
go back to reference Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, Iehara N, Fukatsu A, Kita T, Doi T: Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem. 2003, 278 (20): 18229-18234. 10.1074/jbc.M213266200.CrossRefPubMed Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, Iehara N, Fukatsu A, Kita T, Doi T: Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem. 2003, 278 (20): 18229-18234. 10.1074/jbc.M213266200.CrossRefPubMed
16.
go back to reference Cavet ME, Smolock EM, Ozturk OH, World C, Pang J, Konishi A, Berk BC: Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008, 28 (5): 886-891. 10.1161/ATVBAHA.108.162693.PubMedCentralCrossRefPubMed Cavet ME, Smolock EM, Ozturk OH, World C, Pang J, Konishi A, Berk BC: Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008, 28 (5): 886-891. 10.1161/ATVBAHA.108.162693.PubMedCentralCrossRefPubMed
17.
go back to reference Hung YJ, Lee CH, Chu NF, Shieh YS: Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care. 2010, 33 (8): 1840-1844. 10.2337/dc09-1073.PubMedCentralCrossRefPubMed Hung YJ, Lee CH, Chu NF, Shieh YS: Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care. 2010, 33 (8): 1840-1844. 10.2337/dc09-1073.PubMedCentralCrossRefPubMed
18.
go back to reference Goruppi S, Ruaro E, Schneider C: Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene. 1996, 12 (3): 471-480.PubMed Goruppi S, Ruaro E, Schneider C: Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene. 1996, 12 (3): 471-480.PubMed
19.
go back to reference Goruppi S, Ruaro E, Varnum B, Schneider C: Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3 T3 fibroblasts. Mol Cell Biol. 1997, 17 (8): 4442-4453.PubMedCentralCrossRefPubMed Goruppi S, Ruaro E, Varnum B, Schneider C: Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3 T3 fibroblasts. Mol Cell Biol. 1997, 17 (8): 4442-4453.PubMedCentralCrossRefPubMed
20.
go back to reference Goruppi S, Ruaro E, Varnum B, Schneider C: Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene. 1999, 18 (29): 4224-4236. 10.1038/sj.onc.1202788.CrossRefPubMed Goruppi S, Ruaro E, Varnum B, Schneider C: Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene. 1999, 18 (29): 4224-4236. 10.1038/sj.onc.1202788.CrossRefPubMed
21.
go back to reference Holland SJ, Powell MJ, Franci C, Chan EW, Friera AM, Atchison RE, McLaughlin J, Swift SE, Pali ES, Yam G, Wong S, Lasaga J, Shen MR, Yu S, Xu W, Hitoshi Y, Bogenberger J, Nor JE, Payan DG, Lorens JB: Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res. 2005, 65 (20): 9294-9303. 10.1158/0008-5472.CAN-05-0993.CrossRefPubMed Holland SJ, Powell MJ, Franci C, Chan EW, Friera AM, Atchison RE, McLaughlin J, Swift SE, Pali ES, Yam G, Wong S, Lasaga J, Shen MR, Yu S, Xu W, Hitoshi Y, Bogenberger J, Nor JE, Payan DG, Lorens JB: Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res. 2005, 65 (20): 9294-9303. 10.1158/0008-5472.CAN-05-0993.CrossRefPubMed
22.
go back to reference Gallicchio M, Mitola S, Valdembri D, Fantozzi R, Varnum B, Avanzi GC, Bussolino F: Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood. 2005, 105 (5): 1970-10.1182/blood-2004-04-1469.CrossRefPubMed Gallicchio M, Mitola S, Valdembri D, Fantozzi R, Varnum B, Avanzi GC, Bussolino F: Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood. 2005, 105 (5): 1970-10.1182/blood-2004-04-1469.CrossRefPubMed
23.
go back to reference Li Y, Ye X, Tan C, Hongo JA, Zha J, Liu J, Kallop D, Ludlam MJ, Pei L: Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene. 2009, 28 (39): 3442-3455. 10.1038/onc.2009.212.CrossRefPubMed Li Y, Ye X, Tan C, Hongo JA, Zha J, Liu J, Kallop D, Ludlam MJ, Pei L: Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene. 2009, 28 (39): 3442-3455. 10.1038/onc.2009.212.CrossRefPubMed
24.
go back to reference Korshunov VA, Mohan AM, Georger MA, Berk BC: Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res. 2006, 98 (11): 1446-1452. 10.1161/01.RES.0000223322.16149.9a.CrossRefPubMed Korshunov VA, Mohan AM, Georger MA, Berk BC: Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res. 2006, 98 (11): 1446-1452. 10.1161/01.RES.0000223322.16149.9a.CrossRefPubMed
25.
go back to reference Korshunov VA, Daul M, Massett MP, Berk BC: Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension. Hypertension. 2007, 50 (6): 1057-1062. 10.1161/HYPERTENSIONAHA.107.096289.CrossRefPubMed Korshunov VA, Daul M, Massett MP, Berk BC: Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension. Hypertension. 2007, 50 (6): 1057-1062. 10.1161/HYPERTENSIONAHA.107.096289.CrossRefPubMed
26.
go back to reference D'Arcangelo D, Gaetano C, Capogrossi MC: Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res. 2002, 91 (7): e4-12. 10.1161/01.RES.0000036753.50601.E9.CrossRefPubMed D'Arcangelo D, Gaetano C, Capogrossi MC: Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res. 2002, 91 (7): e4-12. 10.1161/01.RES.0000036753.50601.E9.CrossRefPubMed
27.
go back to reference Konishi A, Aizawa T, Mohan A, Korshunov VA, Berk BC: Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J Biol Chem. 2004, 279 (27): 28766-28770. 10.1074/jbc.M401977200.CrossRefPubMed Konishi A, Aizawa T, Mohan A, Korshunov VA, Berk BC: Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J Biol Chem. 2004, 279 (27): 28766-28770. 10.1074/jbc.M401977200.CrossRefPubMed
28.
go back to reference Son BK, Kozaki K, Iijima K, Eto M, Nakano T, Akishita M, Ouchi Y: Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol. 2007, 556 (1–3): 1-8.CrossRefPubMed Son BK, Kozaki K, Iijima K, Eto M, Nakano T, Akishita M, Ouchi Y: Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol. 2007, 556 (1–3): 1-8.CrossRefPubMed
29.
go back to reference Kim H, Kim HJ, Lee K, Kim JM, Kim HS, Kim JR, Ha CM, Choi YK, Lee SJ, Kim JY, Harris RA, Jeong D, Lee IK: alpha-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J Cell Mol Med. 2012, 16 (2): 273-286. 10.1111/j.1582-4934.2011.01294.x.PubMedCentralCrossRefPubMed Kim H, Kim HJ, Lee K, Kim JM, Kim HS, Kim JR, Ha CM, Choi YK, Lee SJ, Kim JY, Harris RA, Jeong D, Lee IK: alpha-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J Cell Mol Med. 2012, 16 (2): 273-286. 10.1111/j.1582-4934.2011.01294.x.PubMedCentralCrossRefPubMed
31.
go back to reference Sheetz MJ, King GL: Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA. 2002, 288 (20): 2579-2588. 10.1001/jama.288.20.2579.CrossRefPubMed Sheetz MJ, King GL: Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA. 2002, 288 (20): 2579-2588. 10.1001/jama.288.20.2579.CrossRefPubMed
32.
go back to reference Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A: Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999, 99 (17): 2239-2242. 10.1161/01.CIR.99.17.2239.CrossRefPubMed Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A: Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999, 99 (17): 2239-2242. 10.1161/01.CIR.99.17.2239.CrossRefPubMed
33.
go back to reference Varma S, Lal BK, Zheng R, Breslin JW, Saito S, Pappas PJ, Hobson RW, Duran WN: Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am J Physiol Heart Circ Physiol. 2005, 289 (4): H1744-1751. 10.1152/ajpheart.01088.2004.PubMedCentralCrossRefPubMed Varma S, Lal BK, Zheng R, Breslin JW, Saito S, Pappas PJ, Hobson RW, Duran WN: Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am J Physiol Heart Circ Physiol. 2005, 289 (4): H1744-1751. 10.1152/ajpheart.01088.2004.PubMedCentralCrossRefPubMed
34.
go back to reference Hasanbasic I, Rajotte I, Blostein M: The role of gamma-carboxylation in the anti-apoptotic function of gas6. J Thromb Haemost. 2005, 3 (12): 2790-2797. 10.1111/j.1538-7836.2005.01662.x.CrossRefPubMed Hasanbasic I, Rajotte I, Blostein M: The role of gamma-carboxylation in the anti-apoptotic function of gas6. J Thromb Haemost. 2005, 3 (12): 2790-2797. 10.1111/j.1538-7836.2005.01662.x.CrossRefPubMed
35.
go back to reference Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, Colonna M, Torre V, Russo G, Sardella A, Urna G, Campo GM, Cavallari V, Squadrito G, Squadrito F: Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes. 2001, 50 (3): 667-674. 10.2337/diabetes.50.3.667.CrossRefPubMed Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, Colonna M, Torre V, Russo G, Sardella A, Urna G, Campo GM, Cavallari V, Squadrito G, Squadrito F: Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes. 2001, 50 (3): 667-674. 10.2337/diabetes.50.3.667.CrossRefPubMed
36.
go back to reference Pinter E, Haigh J, Nagy A, Madri JA: Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol. 2001, 158 (4): 1199-1206. 10.1016/S0002-9440(10)64069-2.PubMedCentralCrossRefPubMed Pinter E, Haigh J, Nagy A, Madri JA: Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol. 2001, 158 (4): 1199-1206. 10.1016/S0002-9440(10)64069-2.PubMedCentralCrossRefPubMed
37.
go back to reference Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000, 6 (4): 389-395. 10.1038/74651.CrossRefPubMed Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000, 6 (4): 389-395. 10.1038/74651.CrossRefPubMed
38.
go back to reference Goruppi S, Chiaruttini C, Ruaro ME, Varnum B, Schneider C: Gas6 induces growth, beta-catenin stabilization, and T-cell factor transcriptional activation in contact-inhibited C57 mammary cells. Mol Cell Biol. 2001, 21 (3): 902-915. 10.1128/MCB.21.3.902-915.2001.PubMedCentralCrossRefPubMed Goruppi S, Chiaruttini C, Ruaro ME, Varnum B, Schneider C: Gas6 induces growth, beta-catenin stabilization, and T-cell factor transcriptional activation in contact-inhibited C57 mammary cells. Mol Cell Biol. 2001, 21 (3): 902-915. 10.1128/MCB.21.3.902-915.2001.PubMedCentralCrossRefPubMed
39.
go back to reference Angelillo-Scherrer A, Burnier L, Flores N, Savi P, DeMol M, Schaeffer P, Herbert JM, Lemke G, Goff SP, Matsushima GK, Earp HS, Vesin C, Hoylaerts MF, Plaisance S, Collen D, Conway EM, Wehrle-Haller B, Carmeliet P: Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest. 2005, 115 (2): 237-246. 10.1172/JCI22079.PubMedCentralCrossRefPubMed Angelillo-Scherrer A, Burnier L, Flores N, Savi P, DeMol M, Schaeffer P, Herbert JM, Lemke G, Goff SP, Matsushima GK, Earp HS, Vesin C, Hoylaerts MF, Plaisance S, Collen D, Conway EM, Wehrle-Haller B, Carmeliet P: Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest. 2005, 115 (2): 237-246. 10.1172/JCI22079.PubMedCentralCrossRefPubMed
40.
go back to reference McCloskey P, Fridell YW, Attar E, Villa J, Jin Y, Varnum B, Liu ET: GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J Biol Chem. 1997, 272 (37): 23285-23291. 10.1074/jbc.272.37.23285.CrossRefPubMed McCloskey P, Fridell YW, Attar E, Villa J, Jin Y, Varnum B, Liu ET: GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J Biol Chem. 1997, 272 (37): 23285-23291. 10.1074/jbc.272.37.23285.CrossRefPubMed
Metadata
Title
High glucose induces human endothelial dysfunction through an Axl-dependent mechanism
Authors
Chien-Hsing Lee
Yi-Shing Shieh
Fone-Ching Hsiao
Feng-Chih Kuo
Chih-Yuan Lin
Chang-Hsun Hsieh
Yi-Jen Hung
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2014
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-13-53

Other articles of this Issue 1/2014

Cardiovascular Diabetology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.